News/Events

Phased re-start of non-COVID-19 research

In line with NIHR guidance, we are beginning the process of phased re-opening of some non-COVID-19 research studies, while maintaining our contribution to local and nationally prioritised urgent public health studies for COVID-19.Read more

Rapid COVID-19 test halves patient waiting times

A new diagnostic test that can diagnose COVID-19 in a hospital setting faster than standard testing methods has been able to halve patients waiting times.Read more

Cambridgeshire Trusts join COVID-19 vaccine trial

Three leading NHS Trusts in Cambridgeshire are collaborating on a COVID-19 vaccine trial which has been developed by the University of Oxford.Read more

Prestigious fellowship election for NIHR Cambridge BRC researchers

The NIHR Cambridge BRC is delighted that three of our researchers have been elected as Fellows of the Academy of Medical Sciences.Read more

Cambridge study to trial widely used drug to protect healthcare staff from COVID-19.

The PROLIFIC study (ChemoPROphyLaxIs For covId-19 infeCtious disease) aims to determine whether hydroxychloroquine (HCQ), a widely used anti-malarial drug, is effective at preventing or reducing COVID-19 infection in frontline healthcare workers.Read more

POPStar study launches to investigate how pregnancy data can predict future health

A new study from the Departments of Obstetrics & Gynaecology and Paediatrics at the University of Cambridge is investigating how conditions in the womb can predict the future health of mothers and their children.Read more

Over 150 participants recruited to new COVID-19 research programme

A “library” of valuable biological samples from people with COVID-19, which will help scientists globally fight the virus, has recruited its 150th participant.Read more

Cambridge trial targets immune response to treat COVID-19 patients

A new national study, supported by the NIHR Cambridge Biomedical Research Centre and the Cambridge Clinical Trials Unit will test whether two drugs that are already in use to treat other immune-related conditions Read more

Genetic analysis reveals new causes of Primary Immunodeficiency (PID)

A UK-wide research collaboration through the National Institute for Health Research (NIHR) BioResource for Rare Diseases has combined whole genome sequencing (WGS) with a statistical program called BeviMed to predict the existence of disease-causing changes in the DNA of people with Primary Immunodeficiency (PID).  Read more

NIHR Cambridge BRC and CRF begin working on new COVID-19 study

Research staff from NIHR Cambridge Clinical Research Facility (CRF) are being deployed onto the wards at Cambridge University Hospitals (CUH) to start using a new test for a research trial into COVID-19.Read more

Fast-track HRA review of COVID-19 studies

The Health Research Authority (HRA) is working with the rest of the research system to provide a coordinated process so that COVID-19 research can progress quickly, using a fast-track review process with bespoke Read more

First Addenbrooke’s Patient in National COVID-19 Trial

Today, Addenbrooke’s Hospital has enrolled our first patient into the national RECOVERY trial, led by Oxford researchers, which is hoping to identify potential treatments for COVID-19. The Randomised Evaluation of COVid-19 thERapY (RECOVERY) Read more

Discover more

If you would like more information about NIHR Cambridge BRC, please contact us.

Events Calendar

Listing relevant events and training sessions for researchers and members of the public.